BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9416403)

  • 1. Comment: clinical experiences of visual disturbances with nilutamide.
    Dijkman GA; Klotz LH; Diokno AC; Zippe CD
    Ann Pharmacother; 1997 Dec; 31(12):1550-2. PubMed ID: 9416403
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiandrogen withdrawal syndrome with nilutamide.
    Gomella LG; Ismail M; Nathan FE
    J Urol; 1997 Apr; 157(4):1366. PubMed ID: 9120950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fatal fulminating hepatitis caused by nilutamide. A new case].
    Marty F; Godart D; Doermann F; Mérillon H
    Gastroenterol Clin Biol; 1996; 20(8-9):710-1. PubMed ID: 8977826
    [No Abstract]   [Full Text] [Related]  

  • 4. Nilutamide-induced neutropenia.
    Eaton VS; Blackmore TK
    BJU Int; 2001 Nov; 88(7):801-2. PubMed ID: 11890258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal fulminant hepatitis induced by nilutamide (Anandron)].
    Pescatore P; Hammel P; Durand F; Bertheau P; Bernuau J; Huc D; Gerbal JL; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1993; 17(6-7):499-501. PubMed ID: 8243938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary toxicity of nilutamide (Anandron). Cooperative evaluation of French Regional Pharmacovigilance Centers].
    Jonville AP; Diot E; Dutertre JP; Autret E
    Therapie; 1992; 47(5):393-7. PubMed ID: 1299978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular toxicity of anandron.
    Brisset JM; Bertagna C; Proulx L
    Br J Ophthalmol; 1987 Aug; 71(8):639-40. PubMed ID: 3651380
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary complications of hormone treatment in prostate carcinoma.
    Seigneur J; Trechot PF; Hubert J; Lamy P
    Chest; 1988 May; 93(5):1106. PubMed ID: 3129240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nilutamide: an antiandrogen for the treatment of prostate cancer.
    Dole EJ; Holdsworth MT
    Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug.
    Ask K; Dijols S; Giroud C; Casse L; Frapart YM; Sari MA; Kim KS; Stuehr DJ; Mansuy D; Camus P; Boucher JL
    Chem Res Toxicol; 2003 Dec; 16(12):1547-54. PubMed ID: 14680368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications of antiandrogens in benign hyperplasia of the prostate].
    Benassayag E
    J Urol (Paris); 1995; 101(2):109-10. PubMed ID: 8522854
    [No Abstract]   [Full Text] [Related]  

  • 12. Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.
    Brisset JM; Boccon-Gibod L; Botto H; Camey M; Cariou G; Duclos JM; Duval F; Gontiès D; Jorest R; Lamy L
    Prog Clin Biol Res; 1987; 243A():411-22. PubMed ID: 3309973
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of RU 23908 (nilutamide) in prostatic cancer].
    Akaza H; Aso Y; Niijima T; Fuse H; Izaka S; Akimoto S; Shimazaki J; Imai K; Yamanaka H; Kihara K
    Hinyokika Kiyo; 1991 Apr; 37(4):407-20. PubMed ID: 1892002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of nilutamide.
    Gaillard-Moguilewsky M; de Gery A; Ulmann A
    Cancer; 1993 Dec; 72(12 Suppl):3828-9. PubMed ID: 8252498
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumonitis and non steroidal antiandrogens.
    Prescrire Int; 2003 Aug; 12(66):141. PubMed ID: 12908492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant hepatic failure due to nilutamide hepatotoxicity.
    Merwat SN; Kabbani W; Adler DG
    Dig Dis Sci; 2009 Apr; 54(4):910-3. PubMed ID: 18688719
    [No Abstract]   [Full Text] [Related]  

  • 17. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.
    Kassouf W; Tanguay S; Aprikian AG
    J Urol; 2003 May; 169(5):1742-4. PubMed ID: 12686822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed dark adaptation caused by nilutamide.
    Chan P; Odel JG
    J Neuroophthalmol; 2008 Jun; 28(2):158-9. PubMed ID: 18562852
    [No Abstract]   [Full Text] [Related]  

  • 19. Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer.
    Eastham JA; Sartor O
    J Urol; 1998 Mar; 159(3):990. PubMed ID: 9474206
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung caught in Nilutamide treatment.
    Lourenço EP; Nzwalo H; Sampaio MR; Brito H
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27599808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.